Pacira Pharm Inc (PCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2015 | 12-2014 | 09-2014 | 06-2014 | 03-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,260 | -13,716 | -19,518 | -16,514 | -11,477 |
| Depreciation Amortization | 3,900 | 14,661 | 10,797 | 7,248 | 3,760 |
| Accounts receivable | -2,145 | -7,776 | -5,927 | -5,955 | -1,379 |
| Accounts payable and accrued liabilities | -5,679 | 15,349 | 9,560 | 5,226 | -1,531 |
| Other Working Capital | -13,547 | 639 | 3,207 | 3,079 | -1,002 |
| Other Operating Activity | 15,341 | 17,407 | 13,723 | 10,398 | 6,893 |
| Operating Cash Flow | $-870 | $26,564 | $11,842 | $3,482 | $-4,736 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 9,694 | -84,017 | -72,394 | 3,949 | 13,826 |
| PPE Investments | -7,874 | -22,984 | -14,161 | -9,831 | -3,808 |
| Net Acquisitions | -1,620 | -13,433 | -11,720 | -2,192 | -999 |
| Purchase Of Investment | N/A | N/A | -24,465 | -13,481 | N/A |
| Investing Cash Flow | $200 | $-120,434 | $-122,740 | $-21,555 | $9,019 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 4,047 | 118,875 | 116,139 | 113,758 | 1,964 |
| Financing Cash Flow | $4,047 | $118,875 | $116,139 | $113,758 | $1,964 |
| Beginning Cash Position | 37,520 | 12,515 | 12,515 | 12,515 | 12,515 |
| End Cash Position | 40,897 | 37,520 | 17,756 | 108,200 | 18,762 |
| Net Cash Flow | $3,377 | $25,005 | $5,241 | $95,685 | $6,247 |
| Free Cash Flow | |||||
| Operating Cash Flow | -870 | 26,564 | 11,842 | 3,482 | -4,736 |
| Capital Expenditure | -7,874 | -22,984 | -14,161 | -9,831 | -3,808 |
| Free Cash Flow | -8,744 | 3,580 | -2,319 | -6,349 | -8,544 |